Login
Who's Online
We have 241 guests and no members online
Statistics
- Users 5691
- Articles 789
- Articles View Hits 19291928
Why Use This Site for Advertisement?
| Thank you for your interest in advertising on Gene Therapy Net. The website is active since January 2008 and the site's traffic grows day by day (see statistics). The visitors of Gene Therapy Net are professionals, doctors and researchers, as well as students, patients, regulatory affairs officers, government policy officers, and everyone else interested in gene therapy. |
|
| Gene Therapy Net is run by a policy officer in the clinical gene therapy trial assessment procedure in the Netherlands. He has a scientific background in molecular biology and immunology. The website is a non-governmental, personal initiative and is aimed to provide comprehensive and accurate information about gene therapy, clinical trials, research news, and relevant gene therapy regulation and legislation. |
Advertisement Opportunities
Full banners, cube banners and text ads will be placed on highly visible sections throughout the site. Cube banners and text ads are placed in the left columns of the site, whereas full banners are placed in the middle wide column of the site. Your banner or text ad will be hyperlinked to the web address of your choice.
There are four different types of campaigns:
| 1 | Full banner | Located in rotation with other banners on all pages, including the home page |
| 2 | Home page banner or text links | Located only on the home page. Always visible in 1st or 2nd news item in center of the home page |
| 3 | Cube banner | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
| 4 | Text links | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
Advertisement Rates
We suggest a minimum of 3 months or at least 10,000 impressions, but please keep in mind that these rates and time lengths are not set in stone, but rather displayed to give you an idea on how our ad pricing is usually structured. By advertising on Gene Therapy Net, you agree to our terms and conditions listed below.
Contact us for more information about advertising.
Advertising Terms and Conditions: All ads are reviewed for correct usage, and must be approved prior to publication. Gene Therapy Net reserves the right to refuse advertising privileges to any web site for any reason, including the promotion of pornographic products and/or content, the advocating of illegal activities, immoral conduct, plagiarism, cheating, etc. Gene Therapy Net shall not be held responsible for grammatical errors, typographical errors, or errors in artwork provided by the advertiser. All ads are at the discretion of Gene Therapy Net. All rates are agreed on before advertisement is placed. Your ad will be place after full payment has been received. When an order has been received and payment taken for the service there will be no refund to the advertiser. Gene Therapy Net reserves the right to modify, change or otherwise improve upon the design and format of any or all of its pages at any time without notice. Gene Therapy Net reserves the right to modify, eradicate and/or change any or all of these terms and conditions without notice, including the right to change the above rates or to terminate this advertising program. We appreciate, but do not require, reciprocal links to Gene Therapy Net to be posted on your site.
Suggestions
Gene Therapy News
- Nine Tumour Reports Raise Safety Questions Over Gene Therapy - The Indian Practitioner
Sat, 07 Nov 2026 07:54:3 GMT - FDA Probes Cancer Risk After Tumours Reported In Children Given Novartis's SMA Gene Therapy - Health and Me
Sat, 07 Nov 2026 06:30:0 GMT - FDA Investigates Tumor Risk After Novartis Zolgensma Gene Therapy: 5 outlets compared - NewsCord
Sat, 07 Nov 2026 06:19:2 GMT - FDA investigates tumour risk linked to Novartis' Zolgensma gene therapy - BusinessLine
Sat, 07 Nov 2026 04:55:2 GMT - FDA probes tumour risk tied to Novartis gene therapy - TradingView
Sat, 07 Nov 2026 03:31:0 GMT - FDA Says It Is Investigating Serious Malignancy Risk Linked To Zolgensma Gene Therapy - TradingView
Sat, 07 Nov 2026 02:22:2 GMT - Fewer Than 40 People Worldwide Share 4-Year-Old Felix Kennedy’s Disease, So His Peachtree City Mom Started a Nonprofit to Fund a Gene Therapy - AOL.com
Sat, 07 Nov 2026 00:00:0 GMT - Pioneering gene therapy helps 'boy in bubble' have normal life - BBC
Fri, 06 Nov 2026 23:57:1 GMT - Gene Therapy Shows Durable Benefit in Wiskott–Aldrich Syndrome - Physicians Weekly
Fri, 06 Nov 2026 22:38:3 GMT - EP PerMed Cell and Gene Therapy Research Call 2027 - Oncodaily
Fri, 06 Nov 2026 22:36:0 GMT - Who Should Track Gene Therapy Outcomes Long Term? ASTCT Panel Debates Shared Responsibility - Pharmacy Times
Fri, 06 Nov 2026 21:48:3 GMT - Novartis confirms 2 tumor cases appear tied to SMA gene therapy - SMA News Today
Fri, 06 Nov 2026 20:08:5 GMT - Cell Therapy Weekly: BLA for Huntington’s Disease Gene Therapy Accepted for Review - RegMedNet
Fri, 06 Nov 2026 19:59:1 GMT - Does Zolgensma cause tumors? Novartis reports nine cases since 2019, two with gene therapy DNA found - Nacionale
Fri, 06 Nov 2026 18:24:5 GMT - Novartis reveals cancer cases possibly linked to gene therapy Zolgensma - BioPharma Dive
Fri, 06 Nov 2026 18:06:5 GMT
